Trends in fat consumption I read the paper ‘Trends in individual fat consumption in the UK 1900-1985’ by A. M. Stephen and G. M. Sieber (1994) with interest. This is an important subject for anyone concerned with possible links between fat consumption and chronic disease, especially in view of the intense educative activity about dietary fats that is now being encouraged. Try as I may, I cannot...

Soybean is one of the world’s most important crops, offering a stable source of materials for food, feed, industrial, and pharmaceutical applications. Soybean seeds contain a high content of nutritious protein and oil, and assume an important part of traditional foods in many Asian countries, including Japan. They are also abundant in physiologically active metabolites and functional proteins, ...

As part of its responsibilities under various Acts of Parliament, MAFF Directorate of Fisheries Research has a duty to carry out a substantial programme of monitoring, surveillance and research in relation to the quality of the aquatic environment in and around the United Kingdom. In the course of that programme, a wide variety of methods of analysis are used for a wide variety of contaminants,...

Regarding the fattening of younger cattle that the Ministry of Agriculture Forestry and Fisheries (MAFF) recommends in Japan, this study looked at vitamin A control in feed and blood and its effect on performance of production and carcass composition of Wagyu steers. Five sets from 10 Wagyu artificial identical twins were divided to into 2 groups, a restricted group (Test) and a supplied group ...

Transcription regulatory genes are crucial modulators of cell physiology and metabolism whose intracellular levels are tightly controlled in response to extracellular stimuli. We previously reported a set of 29 transcription regulatory genes modulated by angiotensin II in H295R human adrenocortical cells and their roles in regulating the expression of the last and unique enzymes of the glucocor...

BACKGROUND Alefacept treatment is highly effective in a select group patients with moderate-to-severe psoriasis, and is an ideal candidate to develop systems to predict who will respond to therapy. A clinical trial of 22 patients with moderate to severe psoriasis treated with alefacept was conducted in 2002-2003, as a mechanism of action study. Patients were classified as responders or non-resp...